Local and systemic IgE in the evaluation and treatment of allergy.
Traditional descriptions of type I hypersensitivity and its manifestations center on systemic immunoglobulin E (IgE)-mediated reactions to inciting antigens. Hence, many current diagnostic and therapeutic measures are based on systemic skin testing for allergy, systemic pharmacotherapy, and immunotherapy. Recent developments in rhinology and pulmonology, particularly in defining the phenomenon of local IgE production in various airway inflammatory conditions, have an impact on both medical and surgical diagnosis and management of these conditions. This review includes a discussion of allergy as a systemic disease, current systemic diagnostic and management strategies for allergy, and local IgE presence and synthesis in the upper and lower airways.
Hoddeson
Elizabeth K
EK
Department of Otolaryngology-Head and Neck Surgery, Emory University, 1365A Clifton Road NE, Suite A2300, Atlanta, GA 30322, USA.
Pratt
Eleanor
E
Harvey
Richard J
RJ
Wise
Sarah K
SK
D000281:Administration, Intranasal; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D006633:Histamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D007167:Immunotherapy / Q000379:methods; D008168:Lung / Q000276:immunology; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy*
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D006633:Histamine Antagonists; D007073:Immunoglobulin E